Coeptis Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$21,266,537 over the previous period. Total operating expenses were $20,489,888.
Profit Margin
| 2019 | 0 | -2.23K | |
|---|---|---|---|
| 2020 | 30.76K | -7.00M | -22787.28% |
| 2021 | 75K | -14.42M | -19229.6% |
| 2022 | 0 | -40.96M | |
| 2023 | 0 | -21.26M |
COEP Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 75K | 30.76K | 0 |
Cost of revenue | 1.00M | 1.00M | 447.41K | 964.21K | 0 |
Gross profit | -1.00M | -1.00M | -372.41K | -933.45K | 0 |
Operating exp. | |||||
Research and development | 6.66M | 20.88K | 0 | 3.54K | 0 |
Selling and marketing | 12.71K | 8.33K | 2.91K | 6.60K | 0 |
Total operating expenses | 20.48M | 34.19M | 14.12M | 5.77M | 0 |
Operating income | -21.49M | -34.19M | -14.04M | -6.86M | 0 |
Other income (expenses), net | 224.58K | -3.37M | 596.65K | -2.29M | -2.23K |
Income before tax | -21.26M | -37.57M | -13.44M | -9.15M | -2.23K |
Income tax expense | 0 | 3.39M | 972.91K | -2.14M | 0 |
Net income | -21.26M | -40.96M | -14.42M | -7.00M | -2.23K |
Earnings per share | |||||
Basic EPS | -0.83 | -2.87 | -0.71 | -0.34 | -0.00 |
Diluted EPS | -0.83 | -2.87 | -0.71 | -0.34 | -0.00 |
| Data source | Data source | Data source |